AMHCW (Amplitude Healthcare Acquisition) Interest Expense : $0.00 Mil (TTM As of Jun. 2021)

View and export this data going back to 2020. Start your Free Trial

What is Amplitude Healthcare Acquisition Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Amplitude Healthcare Acquisition's interest expense for the six months ended in Jun. 2021 was $ 0.00 Mil. Its interest expense for the trailing twelve months (TTM) ended in Jun. 2021 was $0.00 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Amplitude Healthcare Acquisition's Operating Income for the six months ended in Jun. 2021 was $ -0.56 Mil. Amplitude Healthcare Acquisition's Interest Expense for the six months ended in Jun. 2021 was $ 0.00 Mil. Amplitude Healthcare Acquisition has no long-term debt ⁽¹⁾. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

(1) Note: An indication of "no long-term debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

Amplitude Healthcare Acquisition Interest Expense Historical Data

The historical data trend for Amplitude Healthcare Acquisition's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Amplitude Healthcare Acquisition Interest Expense Chart

Amplitude Healthcare Acquisition Annual Data

Trend

Dec19

Dec20

Interest Expense

Amplitude Healthcare Acquisition Semi-Annual Data
	Aug19	Sep19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21
Interest Expense	Get a 7-Day Free Trial			-	-	-	-	-

Amplitude Healthcare Acquisition Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

For stock reported annually, GuruFocus uses latest annual data as the TTM data. Interest Expense for the trailing twelve months (TTM) ended in Jun. 2021 was $0.00 Mil.

Amplitude Healthcare Acquisition (NAS:AMHCW) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Amplitude Healthcare Acquisition's Interest Expense for the six months ended in Jun. 2021 was $0.00 Mil. Its Operating Income for the six months ended in Jun. 2021 was $-0.56 Mil. And its Long-Term Debt & Capital Lease Obligation for the six months ended in Jun. 2021 was $0.00 Mil.

Amplitude Healthcare Acquisition's Interest Coverage for the quarter that ended in Jun. 2021 is calculated as

Amplitude Healthcare Acquisition had no long-term debt ⁽¹⁾.

The higher the ratio, the stronger the company's financial strength is.

Good Sign:

Amplitude Healthcare Acquisition Corp has no debt.

Amplitude Healthcare Acquisition Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Financial Services » Diversified Financial Services » Amplitude Healthcare Acquisition Corp (NAS:AMHCW) » Definitions » Interest Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

1177 Avenue of the Americas, Floor 40, New York, NY, USA, 10036

Website

Amplitude Healthcare Acquisition Corp is a blank check company formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses.

Amplitude Healthcare Acquisition Headlines

From GuruFocus

Jasper Therapeutics and Amplitude Healthcare Acquisition Corporation Announce Two New Board Members

By Business Wire Business Wire • 09-20-2021

Jasper Therapeutics and Amplitude Healthcare Acquisition Corporation Announce Merger to Create a Publicly Listed Leading Biotechnology Company in Hematopoietic Stem Cell Transplantation

By Business Wire Business Wire • 05-06-2021

Amplitude Healthcare Acquisition Corporation Announces the Separate Trading of its Class A Common Stock and Warrants, Commencing January 10, 2020

By Marketwired Marketwired • 01-07-2020

Amplitude Healthcare Acquisition Corporation Announces Pricing of $100,000,000 Initial Public Offering

By Marketwired Marketwired • 11-20-2019

Amplitude Healthcare Acquisition Corporation Announces Closing of $100,000,000 Initial Public Offering

By Marketwired Marketwired • 11-22-2019

Jasper Therapeutics Closes Transaction With Amplitude Healthcare Acquisition Corporation, Creating a Publicly Traded Biotechnology Company Dedicated to Enabling Cures Through Hematopoietic Stem Cell Therapy

By Business Wire Business Wire • 09-24-2021

SHAREHOLDER ALERT: Monteverde & Associates PC Announces an Investigation of Amplitude Healthcare Acquisition Corp. - AMHC

By PRNewswire PRNewswire • 06-08-2021

Amplitude Healthcare Acquisition Corporation Announces Shareholder Approval of Business Combination with Jasper Therapeutics, Inc.

By Marketwired Marketwired • 09-22-2021